Lawmakers requested the report after a 2023 ProPublica and Pittsburgh Post-Gazette investigation revealed that the FDA had ...

On Dec. 5, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to end the ...

Sean D. Hamill, Pittsburgh Post-Gazette, and Melissa Dai, Medill Investigative Lab Lawmakers requested the report after a ...

The continued rise in awareness of mental health conditions and behavioral wellbeing among the broader population was on ...

The History of Advertising Trust is to set up three digital archives for retired agency brands FCB, DDB and MullenLowe. This follows the agency networks being axed a result of Omnicom’s aqusition of ...

Senate rejects dueling healthcare bills as ACA deadline looms; Calls to pull COVID vaccines get louder but the data reiterates safety profile; Zealand Pharma’s GLP-1 strategy.

Citius Oncology entered into an exclusive distribution agreement with Er-Kim to expand international access to Lymphir (denileukin diftitox-cxdl) in Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia ...

Sam Glassenberg, EVP of Relevate Health Games, launched this session at the AI Deciphered conference by pointing out how wholeheartedly the video game industry has embraced generative AI. Indeed, the ...

Myles, who previously worked at National Institutes of Health, shared how the new administration has impacted the federal agency’s communications.

In 2026, the Trump administration will require U.S. cancer registries that receive federal funding to classify patients’ sex as male, female — or not stated/unknown.

More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one backdated for November 24 for Daiichi Sankyo’s tenosynovial giant cell ...

Fresh insights from SiriusXM Media’s 2026 pharma audience research study reveal a clear shift in how and where pharma consumers want to hear from Rx brands today.